Literature DB >> 8103749

A mouse aminopeptidase N is a marker for antigen-presenting cells and appears to be co-expressed with major histocompatibility complex class II molecules.

A S Hansen1, O Norén, H Sjöström, O Werdelin.   

Abstract

To analyze the expression of mouse aminopeptidase N (APN) on the cells of the immune system a panel of rat monoclonal antibodies against mouse intestinal APN was generated. These antibodies were used to affinity purify functional mouse APN from both intestine and kidney, and by flow cytometry to examine the APN expression of the cells of the mouse immune system. An APN closely related, perhaps identical, to the intestinal APN was expressed on a subpopulation of spleen cells and stimulated peritoneal exudate cells, primarily representing antigen-presenting cells, such as B cells, macrophages, dendritic cells, and veiled cells. In contrast this APN expression could not be detected on thymocytes or spleen T cells. As a corollary, APN was expressed on monocyte, macrophage, and B lymphoma cell lines, but not on T hybridoma or thymoma cell lines. The expression of APN showed a striking correlation with the MHC class II expression in all the cell populations studied. This apparent co-expression suggests a role for APN in antigen processing.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8103749     DOI: 10.1002/eji.1830230946

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  15 in total

1.  Major histocompatibility class II molecules prevent destructive processing of exogenous peptides at the cell surface of macrophages for presentation to CD4 T cells.

Authors:  Alexei von Delwig; Julie A Musson; Joe Gray; Norman McKie; John H Robinson
Journal:  Immunology       Date:  2005-02       Impact factor: 7.397

2.  Induction of the membrane alanyl aminopeptidase gene and surface expression in human T-cells by mitogenic activation.

Authors:  U Lendeckel; T Wex; D Reinhold; T Kähne; K Frank; J Faust; K Neubert; S Ansorge
Journal:  Biochem J       Date:  1996-11-01       Impact factor: 3.857

Review 3.  CD13/Aminopeptidase N Is a Potential Therapeutic Target for Inflammatory Disorders.

Authors:  Chenyang Lu; Mohammad A Amin; David A Fox
Journal:  J Immunol       Date:  2020-01-01       Impact factor: 5.422

4.  Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis.

Authors:  R Pasqualini; E Koivunen; R Kain; J Lahdenranta; M Sakamoto; A Stryhn; R A Ashmun; L H Shapiro; W Arap; E Ruoslahti
Journal:  Cancer Res       Date:  2000-02-01       Impact factor: 12.701

5.  Rapid mitogen-induced aminopeptidase N surface expression in human T cells is dominated by mechanisms independent of de novo protein biosynthesis.

Authors:  U Lendeckel; T Wex; A Ittenson; M Arndt; K Frank; O Mayboroda; W Schubert; S Ansorge
Journal:  Immunobiology       Date:  1997-06       Impact factor: 3.144

6.  Distribution of dipeptidyl peptidase IV in patients with chronic tonsillitis.

Authors:  Milan Stankovic; Predrag Vlahovic; Verica Avramovic; Miroljub Todorovic
Journal:  Clin Vaccine Immunol       Date:  2008-04-02

7.  The streptococcal exotoxin streptolysin O activates mast cells to produce tumor necrosis factor alpha by p38 mitogen-activated protein kinase- and protein kinase C-dependent pathways.

Authors:  Michael Stassen; Christian Müller; Christoph Richter; Christine Neudörfl; Lothar Hültner; Sucharit Bhakdi; Iwan Walev; Edgar Schmitt
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

8.  Reduced DEAF1 function during type 1 diabetes inhibits translation in lymph node stromal cells by suppressing Eif4g3.

Authors:  Linda Yip; Remi J Creusot; Cara T Pager; Peter Sarnow; C Garrison Fathman
Journal:  J Mol Cell Biol       Date:  2012-08-24       Impact factor: 6.216

9.  Human coronavirus 229E: receptor binding domain and neutralization by soluble receptor at 37 degrees C.

Authors:  Jamie J Breslin; Irene Mørk; M K Smith; Lotte K Vogel; Erin M Hemmila; Aurelio Bonavia; Pierre J Talbot; Hans Sjöström; Ove Norén; Kathryn V Holmes
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

10.  Anti-CD13 Abs in children with extensive chronic GVHD and their relation to soluble CD13 after allogeneic blood and marrow transplantation from a Children's Oncology Groups Study, ASCT0031.

Authors:  G D E Cuvelier; A Kariminia; H Fujii; S Aslanian; D Wall; F Goldman; S A Grupp; S E Dunn; M Krailo; L H Shapiro; A Gilman; K R Schultz
Journal:  Bone Marrow Transplant       Date:  2010-03-01       Impact factor: 5.483

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.